Pure Global

VIÊN ĐẶT HỖ TRỢ PHỤ KHOA - Vietnam Registration 240000926/PCBB-HN

Access comprehensive regulatory information for VIÊN ĐẶT HỖ TRỢ PHỤ KHOA in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại B medical device is registered under number 240000926/PCBB-HN and manufactured by CÔNG TY CỔ PHẦN LIÊN DOANH CÔNG NGHỆ DƯỢC PHẨM VIỆT Ý. The authorized representative in Vietnam is CÔNG TY TNHH DP MAXCARE VIỆT NAM.

This page provides complete technical specifications, regulatory compliance details, 3 companies making similar products including CÔNG TY CỔ PHẦN LIÊN DOANH CÔNG NGHỆ DƯỢC PHẨM VIỆT Ý, Bika Pharma Pharmaceutical Corporation, and 5 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
3 Competitors
5 Recent Registrations
240000926/PCBB-HN
Registration Details
Vietnam MOH Registration: 240000926/PCBB-HN
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

VIÊN ĐẶT HỖ TRỢ PHỤ KHOA
Risk Class TTBYT Loại B

Registration Details

240000926/PCBB-HN

000.00.19.H26-240419-0029

OVAMIX

01

Company Information

CÔNG TY TNHH DP MAXCARE VIỆT NAM

Technical Details

Helps to create a biologic membrane layer covering the mucous membrane, thereby preventing the mucous membrane of the vagina from coming into contact with inflammatory infection-causing agents, and supporting the regeneration of the vaginal mucosa - Helps to balance pH, clean, and reduce the discharge caused by inflammation. - Helps to alleviate itching, discharge, and discomfort in the genital area. - Supports the treatment and prevention of various types of vaginal infections caused by Gram-negative and Gram-positive bacteria, as well as Candida or Trichomonas infections.

Dates and Status

Apr 25, 2024